A Prospective, Randomised, Placebo-Controlled, Double-Masked, Three-Armed, Multicentre Phase II/III Trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma – The STRONG Study: Study Protocol for a Randomised Controlled Trial

Trials - United Kingdom
doi 10.1186/s13063-017-1861-3